Abbott Laboratories Stock Analysis

Paper Summary:

This paper provides an overview of Abbott Laboratories, a research-based, global pharmaceutical company that discovers, develops, manufactures and markets leading prescription medicines as well as many of the world's best known consumer healthcare products. The paper discusses the company's position in the industry, and the extent of it's global operations. It also analyzes the company's stock, with a risk and return and valuation analysis.

Table of Contents:
Introduction
Background of Abbott Laboratories & Operations
Competition Affecting Abbott's Stock Value
Risk & Return Analysis on Abbott Laboratories Stock
Summary of Financial Data
Du Pont Analysis of Abbott Laboratories
Valuation & CAPM Analysis
Summary of Analysis
Conclusion

From the Paper:

"Abbott's business practices and goals have set the pace for the company's extraordinary portfolio management practices, security of the day to day management of resources, research, and development. Abbott has successfully overcome the uncertainty in drug development and competitive pressures. Abbott's business practices continue to make Abbott a unique company and has assisted the company to maintain its' global stance in the world of pharmaceutical companies.
"Everything done at Abbott Laboratories is a reflection of the company's mission, a commitment to serving the total health-care continuum. Abbott's stock analysis concludes with the fact that competitive pressures call for an unprecedented in-depth analysis monitoring of the company stock's general risk exposure."

Sample of Sources Used:

• Abbott. (2007). About the Company. Retrieved November 9, 2007 from http://www.abbott.com.
• Epsicom. (2007). Abbott Medical Device Company Intelligence Report. Retrieved November 9, 2007 from http://www.piribo.com/publications/medical_devices/companies/abbott_medical_device_company_intelligence_report.html.
• McKinnell, H. (2003). Performance Report. Bayer AG 2003 Annual Review: 1-30.
• Rogers, M. (2003). Risk Management in Real Options Based Pharmaceutical Portfolio Planning. Department of Chemical Engineering, Pennsylvania State University: 241-244.
• Scheuble, B. (2003). Letter from Bernhard Scheuble. Merck Annual Report: 2-47.

More papers on Abbott Laboratories Stock Analysis:

• Case Study # 72425 : "Strategic Audit: Abbott Laboratories"
• Research Paper # 52262 : "Abbott Laboratories and Baxter Corporation"
• Analytical Essay # 105730 : "Abbott Laboratories"

APA Citation:

MLA Citation: